Drugmaker Moderna set off fresh alarm bells in financial markets on Tuesday as the firm’s chief warned that COVID-19 vaccines are unlikely to be as effective against the Omicron variant as they have been against the Delta version. we had with Delta,” Moderna CEO Bancel told the Financial Times in an interview. Britain too has expanded its COVID-19 booster programme amid Omicron fears. Curbs and concernsFirst reported on November 24 from South Africa, Omicron has since spread to over a dozen countries. India, home to the world’s largest vaccine maker, has approved supplies of COVID-19 vaccines to many African countries and said it stands ready to “expeditiously” send more.

Source: Indian Express December 01, 2021 03:07 UTC